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METHODS AND TECHNIQUES
DARPins recognize mTFP1 as novel reagents for in vitro
and in vivo protein manipulations
M. Alessandra Vigano1,*, Dimitri Bieli1,*, Jonas V. Schaefer2,*, Roman P. Jakob3,*, Shinya Matsuda1,
Timm Maier3, Andreas Plückthun2,‡ and Markus Affolter1,‡
ABSTRACT
Over the last few years, protein-based affinity reagents have proven
very helpful in cell and developmental biology. While many of these
versatile small proteins can be expressed both in the intracellular and
extracellular milieu in cultured cells and in living organisms, they can
also be functionalized by fusing them to different protein domains in
order to regulate or modulate their target proteins in diverse manners.
For example, protein binders have been employed to degrade, trap,
localize or enzymatically modify specific target proteins. Whereas
binders tomany endogenous proteins or small protein tags have been
generated, several affinity reagents against fluorescent proteins have
also been created and used to manipulate target proteins tagged with
the corresponding fluorescent protein. Both of these approaches
have resulted in improved methods for cell biological and
developmental studies. While binders against GFP and mCherry
have been previously isolated and validated, we now report the
generation and utilization of designed ankyrin repeat proteins
(DARPins) against the monomeric teal fluorescent protein 1
(mTFP1). Here we use the generated DARPins to delocalize Rab
proteins to the nuclear compartment, in which they cannot fulfil their
regular functions anymore. In the future, such manipulations might
enable the production of acute loss-of-function phenotypes in
different cell types or in living organisms based on direct protein
manipulation rather than on genetic loss-of-function analyses.
KEY WORDS: DARPins, mTFP1, Protein binder, Crystal structure,
Relocalization
INTRODUCTION
Over recent decades, much has been learned about the role of
different proteins in controlling cell proliferation, cell movement,
cell determination and cell differentiation, both in cell culture and
during the development of multicellular animals. To a large extent,
such knowledge was gained by comparing the behaviour of wild-
type and mutant individuals, starting with large-scale genetic
screens (Brenner, 1974; Nüsslein-Volhard and Wieschaus, 1980).
Later, these approaches were complemented with reverse genetic
approaches, which allowed for loss- and gain-of-function studies
that could be controlled with regard to developmental time and
to the targeted tissue (Anderson et al., 2017; Housden et al., 2017;
Nagarkar-Jaiswal et al., 2015, 2017; Venken et al., 2011;
Yamamoto et al., 2014). To further increase the possibilities in
studying protein function, RNAi- and morpholino-oligonucleotide-
based methods were used to induce a reduction in protein levels.
While off-target effects have to be taken into account when studying
protein function with these methods, these approaches, in particular
RNAi, allow for time- and tissue-controlled, genome-wide loss-of-
function analyses (Housden et al., 2017). In all of these approaches,
the level of the target protein is reduced either by the lack of function
of the gene or by decreased levels of mRNA. However, when
studying proteins with a particularly long half-life, or in cases of
maternal contribution of proteins in early embryos, it might be very
difficult or even impossible to deplete the protein of interest and
analyse its contribution to cellular or organismal function.
To circumvent this problem, different approaches allowing the
direct manipulation of protein levels were recently developed. A
number of different methods were established to degrade proteins in
an inducible fashion (Banaszynski et al., 2006; Bonger et al., 2011;
Chung et al., 2015; Harder et al., 2008; Natsume et al., 2016), or to
remove proteins from their place of action and thereby inactivating or
preventing their functions in their native environment, [‘anchor away’
(Haruki et al., 2008) and ‘knocksideways’ (Robinson et al., 2010)]. In
the last few years, optogenetic tools were designed to regulate protein
activity or protein dimerization; these light-controllable tools are now
used in cell and developmental biology to regulate or manipulate
protein function in a more controllable fashion (Buckley et al., 2016;
Guglielmi et al., 2016; Rost et al., 2017).
Recently, another somewhat different approach has emerged
which allows targeting and manipulating proteins in several ways
and in a more systematic manner. Using small protein scaffolds, it
became possible to screen for and isolate binders against proteins of
interest, post-translational modifications of proteins or against
protein tags such as fluorescent proteins (Beghein and Gettemans,
2017; Bieli et al., 2016; Harmansa and Affolter, 2018; Helma et al.,
2015; Plückthun, 2015; Sha et al., 2017). Such protein binders have
been used extensively, e.g. as crystallization chaperones in structural
biology (Batyuk et al., 2016; Manglik et al., 2017), as high-affinity
reagents or sensors (Borg et al., 2015; Braun et al., 2016; Kummer
et al., 2013; Rothbauer et al., 2008; Trinkle-Mulcahy et al., 2008), as
detection reagents in light and super resolution microscopy (Pleiner
et al., 2015; Ries et al., 2012) and for targeting medically relevant
intracellular proteins (Böldicke, 2017; Grebien et al., 2011; Koide
et al., 2012), and these reports serve just as examples.
Furthermore, functionalized protein binders have emerged as
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developmental studies. In most of these studies, binders against
fluorescent proteins were used to target proteins of interest fused to
the corresponding fluorescent proteins. Such functionalized binders
allowed the visualization, the degradation, the delocalization or the
chemical modification of the specific target, and thereby provide
insight into the functional roles of proteins in developmental
processes (reviewed in Beghein and Gettemans, 2017; Helma et al.,
2015; Plückthun, 2015; Sha et al., 2017).
In cell and developmental biology, it is now a standard procedure
to use several fluorescent proteins simultaneously to analyse
complex processes in vivo and in real time. It would therefore be
valuable to have specific binders against many different fluorescent
proteins in order to be able to manipulate and/or follow different
proteins simultaneously. At present, only a limited number of
binders for GFP (green fluorescent protein) and mCherry have been
isolated and characterized (Brauchle et al., 2014; Fridy et al., 2014;
Kubala et al., 2010; Moutel et al., 2016).
Here, we report the selection of designed ankyrin repeat proteins
(DARPins) (Plückthun, 2015) recognizing mTFP1 (monomeric
teal fluorescent protein 1). We characterized these binders both
biochemically and biophysically and determined the three-
dimensional structure of one DARPin-mTFP1 complex. In vivo
functionality of anti-mTFP1 DARPins was demonstrated in
delocalization experiments using Rab proteins. In the future, such
manipulations could enable the generation of acute loss-of-function
phenotypes in different cell types based on protein manipulation
rather than genetic loss-of-function analyses.
RESULTS
We have previously reported the isolation and characterization of
DARPins recognizing GFP and mCherry, including ‘clamp’
constructs (Brauchle et al., 2014; Hansen et al., 2017). To further
increase the number of orthogonal reagents available to selectively
target fluorescent fusion proteins, we wanted to generate DARPins
against a fluorescent protein absorbing and emitting light in a
different range of the light spectrum. We decided to target mTFP1
since at the time it represented the brightest monomeric protein in
the blue-green spectrum (Ai et al., 2006, 2008). mTFP1 was
produced recombinantly in a prokaryotic expression system and
used to select DARPins against this target.
Selection and in vitro characterization of mTFP1-binding
DARPins
To generate suitable DARPin binders, streptavidin-binding peptide
(SBP)-tagged mTFP1 was immobilized on streptavidin beads and
used as a target for DARPin selections by employing multiple
rounds of Ribosome Display (Dreier and Plückthun, 2012;
Plückthun, 2012). In each round, the target concentration
presented on magnetic streptavidin beads was decreased while the
washing stringency was simultaneously increased to enrich for
binders with high affinities. After four rounds of selection, the
enriched pool was cloned into an Escherichia coli expression
vector, allowing the production of both N-terminally His8- and
C-terminally FLAG-tagged DARPins. Nearly 400 colonies of
transformed E. coli were picked and the encoded DARPins were
expressed in small scale. Bacterial crude extracts were subsequently
used in enzyme-linked immunosorbent assay (ELISA) screenings,
detecting the binding of candidate DARPins to streptavidin-
immobilized mTFP1 by employing a FLAG-tag based detection
system (data not shown). The top 30 candidates from these initial
ELISA screens were analysed in more detail, testing their binding to
streptavidin-immobilized mTFP1 and comparing them to the
interaction with streptavidin alone. Of these analysed clones, only
two candidates, named 1238_E11 and 1238_G01, showed a
specific binding to mTFP1 while the majority of previous hits
seemed to also be interacting with free streptavidin. This very
unusually low number in this experiment, compared to the usual
50-200 specific binders, is almost certainly a consequence of
attempting to immobilize the target via a streptavidin-binding
peptide, instead of the usual biotin (see Discussion). The sequence
of the two selected DARPins is shown in Fig. S1A.
Specificity, affinity and epitopes of top two DARPin
candidates
To test whether the selected DARPins 1238_E11 and 1238_G01 are
specific for mTFP1, titration ELISAs against mTFP1, two other
fluorophores (GFP and mCherry) and the Maltose Binding Protein
(MBP) as an unrelated protein target were performed. As shown in
Fig. 1A, both DARPins clearly displayed a specificity for mTFP1,
with apparent affinities in the low nM range (Fig. 1A, blue curves).
However, it was also noted that DARPin 1238_E11 (Fig. 1A, left
panel) had both a higher apparent affinity to the target and higher
background binding compared to DARPins 1238_G01 (Fig. 1A,
right panel).
The affinities of these two DARPins were then measured by
fluorescence anisotropy as previously described (Brauchle et al.,
2014) (Fig. 1B). For DARPins 1238_E11 (left panel), a high
affinity with an equilibrium dissociation constant (KD) value of
3 nM was determined, while the affinity of 1238_G01 was found to
be lower with a value of ∼88 nM.
To analyse whether the two DARPins recognize different, non-
overlapping epitopes on mTFP1, competition/epitope blocking
ELISAs were performed. Streptavidin-immobilized mTFP1 was
incubated with a mixture of FLAG- and HA-tagged DARPins, with
the HA-tagged binders being present at a fivefold higher
concentration over the finally detected FLAG-tagged binders. As
shown in the left panel in Fig. 1C for DARPin 1238_E11, the
presence of neither the non-binding DARPin E3_5 (green striped
bar), nor of the HA-tagged DARPin 1238_G01 (red striped bar) had
reduced the FLAG-based detected signals. However, when the
identical DARPin binder was present as an HA-tagged variant (blue
striped bar), the detected signal was clearly diminished. Similar
results were obtained for DARPin 1238_G01 as shown in the right
panel of Fig. 1C. These data suggest that the two anti-mTFP1
DARPins bind to different epitopes on their target.
Structural analysis of the mTFP1/DARPin 1238_E11 complex
In order to understand the basis for specificity and structural changes
in the binding of the selected DARPins to mTFP1, the crystal
structures of the mTFP1/DARPin 1238_E11 complex were
determined (Fig. 2; Fig. S1). The complex with DARPin
1238_G01 did not crystallize, but the structure of both isolated
DARPins was determined as well (1238_G01, 1.6 Å resolution,
R/Rfree of 16/18) and (1238_E11, 2.1 Å resolution, R/Rfree of 17/21).
The mTFP1/DARPin 1238_E11 complex was obtained by
mixing mTFP1 with a 1.2-fold excess of DARPin 1238_E11 and
subjecting the mixture to gel filtration. Gel filtration analysis
indicated a homogeneous 1:1 complex, which was used for
crystallization as described in Materials and Methods. We
determined the crystal structure of the mTFP1/-DARPin
1238_E11 complex in two space groups, to 1.6 Å (P6522) and
1.85 Å (C2) resolution, respectively (Fig. 2A). Both complex
structures are structurally identical (Cα r.m.s.d. of 0.3 Å): The
overall fold of mTFP1 exhibits the typical β-can motif of the GFP
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family (Yang et al., 1996) and undergoes only minor structural
changes upon DARPin binding (Ai et al., 2006; Henderson et al.,
2007). Similarly, upon mTFP1 binding, DARPin 1238_E11
remains structurally unchanged and exhibits only minor
differences in the N-Cap region (Fig. S1C; Cα r.m.s.d. of 0.45 Å).
DARPin 1238_E11 binds into a cavity along mTFP1 including
β-strands 1, 4, 5 and 6, comprising a protein-protein binding surface
of 790 Å2 (Krissinel and Henrick, 2007) and thus similar in size
Fig. 1. Biochemical analyses of selected anti-mTFP1 DARPins. (A) Titration ELISA: DARPins 1238_E11 (left panel) and 1238_G01 (right panel) show
specific binding to mTFP1 over control surfaces (GFP, mCherry and MBP). (B) Fluorescence anisotropy measurements of 1238_E11 (left panel) and
1238_G01 (right panel) reveal high affinities with KD values of 3 nM and 88 nM, respectively. (C) Epitope blocking ELISA. Immobilized mTFP1 was incubated
with a mixture of HA- and FLAG-tagged DARPins with a relative 1:5 ratio (100 nM of the FLAG-tagged DARPins and 500 nM of the HA-tagged competitor) to
analyse the influence of the competitor on the original signal (shown on left side, named ‘no competition’). All the data shown in this figure originate from
triplicate measurements and error bars indicate standard errors of the mean.
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compared to other known DARPin protein complexes (Gilbreth and
Koide, 2012; Sennhauser and Grütter, 2008). Residues from the
N-Cap and the three DARPin repeats make specific contacts with
mTFP1 (Fig. 2B). Interactions involve hydrophobic DARPin
residues Trp37, Val38, Phe71, Met103 and Val104, two salt
bridges (Asp69-Lys104 and Lys106-Glu15) and an arginine-
arginine paring (Magalhaes et al., 1994; Zhang et al.,
2013)(Arg15-Arg178) stabilized by Glu90 (Fig. 2B).
anti-mTFP1 DARPins bind mTFP1 fusion proteins in
cultured cells
Since many developmental and cellular processes take place in
intracellular compartments, we tested the expression and functionality
of the anti-mTFP1 DARPins within cells. In order to visualize the two
DARPins, we fused 1238_E11 and 1238_G01 to different additional
fluorescent proteins (mCherry or YPet) and used transient transfection
in HeLa cells as a model system to test their properties (Brauchle et al.,
2014; Moutel et al., 2016). The two DARPins 1238_E11 and
1238_G01 were transfected either alone or in combination with
mTFP1 fusion constructs which localize to specific compartments or
specific membranes of the cells. When no mTFP1 was co-expressed,
the DARPin-mCherry fusions alone were uniformly expressed and
localized in both the cytoplasm and nucleus of transfected cells, with
a stronger accumulation in the nuclei (Fig. 3A,B). In contrast, a
mitochondrial mTFP1 ‘bait’ alone (see Materials and Methods for a
description of the mito-mTFP1 construct) was visible at the
mitochondria of the transfected cells (Fig. 3C), due to the fusion
with the N-terminal domain of the outer mitochondrial membrane
protein MitoNEET (CISD1), which is N-terminally anchored to the
outer membrane and exposed to the cytoplasmic outside of the
mitochondria (Colca et al., 2004; Wang et al., 2017) (see Fig. S4 for a
schematic representation of the fusion proteins and Table S2 for their
amino acid sequences). When these two constructs coding for mito-
mTFP1 and DARPin-mCherry were co-transfected, we observed a
clear mitochondrial co-localization (Fig. 3D,E), demonstrating
binding and recruitment of DARPin-mCherry to the mitochondrial
surface via the mitochondrial mTFP1-bait.
Nonetheless, it has to be noted that not all the DARPin molecules
were recruited to the mitochondria, as seen by residual mCherry
signal in the cytoplasm, presumably because of the limited number
of CISD1 binding partners at the mitochondrial surface. Also,
varying the ratio of the transfected DNAs did not change the amount
of DARPins observed at the mitochondria (data not shown).
Furthermore, the different binding affinities of the two DARPins are
also not reflected in this type of experiment: it appears that these
affinities are sufficient to recruit both DARPins to mitochondria in a
very similar way.
To ensure that the specific binding properties of the anti-mTFP1
DARPins would work in many contexts, we also tested them for
co-localization with mTFP1-baits expressed in different cellular
sites (Fig. S2) Thus, we re-localized the DARPin-mCherry fusion
proteins to the nuclear compartment via binding to a histone H2B
(H2B)-mTFP1 fusion (Fig. S2, first row). Indeed, a strong nuclear
co-localization with this bait was observed for both DARPins
(Fig. S2, second and third rows).
Finally, we tested a membrane-localizing mTFP1 bait: mTFP1-
CAAX (mTFP1 with the C-terminal K-Ras farnesylation motif
CVLS) together with the two anti-mTFP1 DARPins. Also in this
combination, we observed a clear co-localization of the mCherry
signal from both DARPin-mCherry fusion proteins with the mTFP1
signal at the cell membrane (Fig. S2, fourth, fifth and sixth rows).
To confirm that the mitochondrial and nuclear co-localizations
with the respective mTFP1 baits were truly mediated by direct
binding of the DARPins to mTFP1 and not by an unspecific
mTFP1-mCherry interaction, we repeated the co-localization
experiments in HeLa cells, fusing the DARPins to YPet, another
fluorescent protein (Nguyen and Daugherty, 2005). The results
shown in Fig. S3 confirmed the specific binding of the DARPin-
YPet constructs to the mTFP1 baits both in the nuclei and at the
mitochondria.
anti-mTFP1 DARPins can be functionalized for in vivo
relocalization experiments
Next, we tested whether the anti-mTFP1 DARPins could bind and
thereby relocalize an mTFP1-fusion protein when stably tethered to
a specific subcellular compartment. For this purpose, we created an
mTFP1-Rab5c fusion construct, where Rab5c would be expected to
be mainly localized to the cytoplasmic face of the early endosome
Fig. 2. Structure of the mTFP1/mTFP1-DARPin 1238_E11 complex. (A) Structural representation of mTFP1 (green) and DARPin 1238_E11 (gray). The
mTFP1 chromophore is shown in sphere representation. (B) Close-up view of the binding interface of mTFP1 (green) and DARPin 1238_E11 (gray). DARPin
residues are labelled in bold; hydrogen bonding interactions are indicated by black dashed lines.
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via its lipid anchors. In an experimental setup similar to the one
previously used for an anti-GFP-DARPin (Brauchle et al., 2014),
we added a CAAX motif to both DARPin-YPet fusion proteins in
order to tether them to the cell membrane, facing towards the
cytoplasm. As anticipated, these DARPin-YPet-CAAX fusions
were localized mostly along the plasma membrane of the transfected
Fig. 3. Intracellular binding of anti-mTFP1-DARPins. Confocal images of HeLa cells transiently transfected with (A) pCMV-DARPin 1238_E11-mCherry
alone, (B) pCMV-DARPin 1238_G01-mCherry alone, (C) pMITO-mTFP1 alone, (D) the combination of pMITO-mTFP1 and pCMV-DARPin 1238_E11-
mCherry and (E) pMITO-mTFP1 and pCMV-DARPin 1238_G01-mCherry. The first column represents the mTFP1 channel (green), the second column is the
mCherry channel (red), the third column is the overlay of the two channels, showing the mitochondrial co-localization (resulting in yellow) of the mito-mTFP1
bait with the respective DARPin, the fourth column represents the nuclear Hoechst staining (blue) and the fifth column is the merge of all three channels.
Images were taken 24 h post transfection. Transfected constructs are indicated on top of each row and the single channels are indicated inside the panels of
the first row. The merge channels are also indicated at the top of the respective columns. The figures are from a representative experiment, performed at
least three times. Scale bars: 15 µm.
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cells (Fig. 4B,C). When transfected alone, the mTFP1-Rab5c fusion
construct showed both a diffuse and a ‘vesicle-like’ distribution,
especially in the perinuclear region, but it was not observed inside
the nucleus (Figs 4A and 5A). In contrast, upon cotransfection with
either of the membrane-tethered DARPins, mTFP1-Rab5c was
relocalized to the plasma membrane (Fig. 4Aversus D,E). Although
Fig. 4. Rab5c recruitment to plasma membrane with anti-mTFP1-DARPins. Confocal images of HeLa cells transiently transfected with (A) pcDNA3-
mTFP1-Rab5c alone, (B) pCMV-DARPin 1238_E11-YPet-CAAX alone, (C) pCMV-DARPin 1238_G01-YPet-CAAX alone, (D) the combination of pcDNA3-
mTFP1-Rab5c and pCMV-DARPin 1238_E11-YPet-CAAX and (E) pcDNA3-mTFP1-Rab5c and pCMV-DARPin 1238_G01-YPet-CAAX. The first column
represents the mTFP1 channel (green), the second column is the YPet channel (red), the third column is the overlay of the two channels, showing the
recruitment of mTFP1-Rab5c to the plasma membranes, the fourth column represents the nuclear Hoechst staining (blue) and the fifth column is the merge
of all three channels. Images were taken 24 h post transfection. Transfected constructs are indicated on top of each row and the single channels are
indicated inside the panels of the first row. The merge channels are also indicated at the top of the respective columns. The figures are from a representative
experiment, performed at least three times. Scale bars: 15 µm.
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some mTFP1-Rab5c was still visible in the perinuclear region, most
of it was relocalized at the plasma membrane under these
cotransfection conditions, thus demonstrating that both anti-
mTFP1 DARPins can be functionalized for in vivo relocalization
experiments.
Reverse anchor away with protein binders
In the previous experiment, we demonstrated the use of DARPins to
actively intervene into a cellular process by relocalizing Rab5c from
its perinuclear localization to the plasma membrane. Another way to
use the intracellular protein binders would be the redistribution of a
Fig. 5. Rab5c trapping in the nucleus with anti-mTFP1-DARPins. Confocal images of HeLa cells transiently transfected with (A) pcDNA3-mTFP1-Rab5c
alone, (B) pCMV-DARPin 1238_E11-YPet-H2B alone, (C) pCMV-DARPin 1238_G01-YPet-H2B alone, (D) the combination of pcDNA3-mTFP1-Rab5c and
pCMV-DARPin 1238_E11-YPet-H2B and (E) pcDNA3-mTFP1-Rab5c and pCMV-DARPin 1238_G01-YPet-H2B. The first column represents the mTFP1
channel (green), the second column is the YPet channel (red), the third column is the overlay of the two channels, showing the recruitment of mTFP1-Rab5c
to the nuclei, the fourth column represents the nuclear Hoechst staining (blue) and the fifth column is the merge of all three channels. Images were taken
24 h post transfection. Transfected constructs are indicated on top of each row and the single channels are indicated inside the panels of the first row. The
merge channels are also indicated at the top of the respective columns. The figures are from a representative experiment, performed at least three times.
Scale bars: 15 µm.
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protein to a place in the cell where it can no longer exert its native
function (Haruki et al., 2008; Robinson et al., 2010). We used
mTFP1-tagged Rab5c together with the anti-mTFP1-DARPins,
with the ultimate aim of removing Rab proteins from their natural
subcellular site of action in the cytoplasm. Therefore, we fused the
anti-mTFP1 DARPins-YPet to histone H2B to stably anchor them
in the nucleus. Upon transfection of HeLa cells, the expression of
the two DARPin-YPet-H2B fusions was exclusively nuclear, with a
stronger accumulation in nucleoli or other unspecified nuclear
bodies as shown in Fig. 5B,C. Cotransfection of mTFP1-Rab5c and
either of the DARPin-YPet-H2B fusions clearly brought most of the
mTFP1-Rab5c signal into the nuclei of the cotransfected cells,
indicating active removal of mTFP1-Rab5c from its site of action,
the cytoplasmic/vesicular compartment (see Fig. 5A versus D,E).
DISCUSSION
Isolation and characterization of novel reagents against
mTFP1
Protein binders against fluorescent proteins are valuable tools in
biochemical research. Here, we report the selection of DARPins
recognizing mTFP1, one of the brightest and most photostable FPs
in the blue-green spectrum. While the two DARPins 1238_E11 and
1238_G01 proved to be of high value for the subsequent cellular
assays, we were surprised to find a rather limited number of hits in
our primary screening that satisfied our precondition of a signal of
40-fold over background. This number of hits is much lower than
that in other selections performed in parallel, where typically 50 to
250 hits are found (data not shown) and this is most likely caused by
the limited affinity of the streptavidin-binding peptide (SBP) to
streptavidin (Keefe et al., 2001). Indeed, the immobilization strategy
and washing steps in the performed Ribosome Display were
previously optimized for the immobilization via biotinylated target
proteins, and biotin binds essentially irreversibly to the streptavidin
beads, while the SBP is washed away. Furthermore, the high
percentage of identified background binders (i.e. DARPins binding
to streptavidin and not mTFP1) is most likely caused by the fact that,
with the immobilization via SBP, the routinely performed
alternations between streptavidin and neutravidin between
different rounds of Ribosome Display could not be employed, as
SBP only binds to streptavidin, but not neutravidin. Therefore, we
cannot recommend replacing biotinylation by streptavidin-binding
peptides. Nevertheless, the two binders identified proved to be
specific, having high affinity and binding to different, non-
overlapping epitopes on mTFP1. This last property may render
these two anti-mTFP1-DARPins suitable for a sandwich pair
(Hansen et al., 2017).
Structure of the mTFP1-DARPin complex
Using X-ray crystallography, we obtained a crystal structure for the
tightest-binding mTFP1 binding DARPin 1238_E11 in complex
with mTFP1. Comparison to the crystal structures of the individual
proteins showed no significant structural changes for both proteins
upon complex formation. DARPin 1238_E11 binds along the barrel
of mTFP1, using hydrophobic and charge complementation
(Fig. 2). Anti-mTFP1 DARPin 1238_E11 and DARPin 1238_
G01 differ in 13 out of 21 selected library residues (Fig. S1A),
suggesting alternative binding epitopes, in line with the ELISA
experiments (Fig. 1C). Recently, the structures of the complexes of
GFP with DARPin 3G61 (PDB ID: 5MAD; Fig. S1D) and DARPin
3G124nc (PDB ID: 5MA6; Fig. S1E) were determined (Hansen
et al., 2017). GFP and mTFP1 show 27% identity and 1.4 Å Cα
r.m.s.d.
DARPin 3G61 and DARPin 3G124nc have an affinity to GFP in
a similarly low nM range as DARPin 1238_E11 to mTFP1
(Brauchle et al., 2014), but use distinct, non-overlapping epitopes to
bind to the barrel of the fluorescent protein (Fig. S1D,E). This
comparison shows how the beta-barrel of the autofluorescent
proteins can be bound from different sides by the DARPin
paratopes.
In vivo performance of the anti-mTFP1-DARPins
Next to other beneficial properties, DARPins fold very well and thus
also display a high solubility in the intracellular milieu (Plückthun,
2015). Indeed, both of the selected anti-mTFP1-DARPins are well
distributed inside the cell and do not form aggregates, even when
overexpressed under the control of the CMV promoter and/or when
fused to different fluorescent proteins (mCherry and YPet) (Fig. 3;
Fig. S3). Furthermore, they are able to recognize and specifically
bind mTFP1 in vivo in different subcellular compartments (Fig. 3;
Fig. S2). Despite having different binding affinities, both DARPins,
1238_E11 and 1238_G01, bind in a very similar way inside the
cell, suggesting that both affinities are sufficiently high. More
importantly, both these binders can be ‘functionalized’ in order to
recruit an overexpressed mTFP1-Rab5c fusion protein to the plasma
membrane (Fig. 4) or to trap it in the nucleus (Fig. 5), with likely
different biological consequences. Nuclear relocalization of Rab5c
appears to be rather efficient and might lead to an efficient depletion
from the cytoplasm, allowing to assess the functional consequence
of the absence of this Rab in the cytoplasm [for such analyses, both
functional copies have to be fused to mTFP1 (see below)].
Therefore, these DARPins can now be employed in many
different applications both in vitro and in vivo.
Use of mTFP1 binders in cell and developmental biology
The number of different fluorescent proteins, which vary in their
absorption and emission spectrum as well as in other properties
(stability, photobleaching and their ability to be photoconverted or
photoactivated), has steadily increased over the last decades
(Rodriguez et al., 2017). In order to further manipulate the in vivo
function of proteins of interests fused to such fluorescent moieties, it
would help to have an equally diverse collection of small-protein
binders recognizing these fluorescent proteins. The two DARPins we
report here bind specifically and with high affinity tomTFP1. The use
of these novel reagents will now allow performing more complex
experiments, both in cultured cells and in multicellular organisms.
Similar to the large number of different optogenetic tools developed
over the past years (Rost et al., 2017), the availability of a battery of
binders to different fluorescent proteins would allow for a
multiparametric approach for imaging and manipulation. For
example, we intend to use mTFP1-recognizing DARPins to mis-
localize Rab proteins in the zebrafish vasculature and follow the
behaviour of other cellular processes (e.g. trafficking of luminal and/
or junctional proteins) using available marker proteins fused to GFP
and red fluorescent proteins (mCherry or mKate2); for the latter two
fluorescent proteins, there is a considerable number of transgenic
lines available encoding fusion proteins that can be used. For such
functional studies (either in cell lines or in developing organisms),
both endogenous copies of the gene have to be engineered in such a
way that they encode functional mTFP1-fusion proteins. Using
Crispr/Cas9 technology, this is possible in many systems.
Alternatively, a single rescue copy can be engineered as to encode
a fusion protein, and crossed into a genetic null background of the
corresponding gene. The generation of such lines in zebrafish will
take some time and therefore goes beyond the scope of this study.
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In summary, the novel DARPins we characterize at the structural
and functional level in this study contribute to the growing toolbox
of protein-directed binder modules that can be used in a large variety
of applications (Beghein and Gettemans, 2017; Helma et al., 2015;
Plückthun, 2015) and thus should be of great value for the scientific
community.
MATERIALS AND METHODS
Protein expression and purification
DARPin protein constructs were cloned into pQIq vectors, overexpressed in
E. coli XL1Blue cells and purified as described previously (Brauchle et al.,
2014). For the expression of mTFP1, the gene fragment was cloned into the
expression plasmid pRSFDuet-1 (Novagen), between BamHI and EcoRI
sites, to generate N-terminally hexa-His-SBP-tagged mTFP1 fusion protein
(Keefe et al., 2001). The amino acid sequence of these tagged proteins is
provided in Table S2. The protein was overexpressed in E. coli BL21(DE3).
After lysis of the cells in 50 mM Hepes/NaOH, 250 mM NaCl, pH 7.4,
40 mM imidazole with a sonicator and centrifugation, the proteins were
purified by immobilized metal-affinity chromatography on a Ni-NTA
column. For structural studies, purified mTFP1 and DARPin were mixed in
a 1.2:1 ratio and then subjected to size-exclusion chromatography in 20 mM
Hepes/NaOH pH 7.4 on a Superdex S75 column (GE Healthcare). The
protein complex-containing fractions were pooled and concentrated in
Amicon Ultra units (Millipore).
ELISA and fluorescence anisotropy (FA) assay
Black 384-well Maxisorp plates (Nunc) were coated with 20 µl streptavidin
(66 nM in PBS) overnight and blocked the next day with 100 µl PBS-TB
(PBS containing 0.1% Tween-20 and 0.2% bovine serum albumin). After
washing three times with 100 µl PBS-T, wells were coated with 20 µl of
either in vivo biotinylated GFP, mCherry or MBP (maltose binding protein)
or SBP-tagged mTFP1 at a concentration of 100 nM. Subsequently, 20 µl
purified FLAG-tagged anti-mTFP1 DARPins 1238_E11 and 1238_G01
were applied in concentrations ranging from 1-50 nM and incubated for 1 h.
Following another incubation with a horseradish peroxidase (HRP)-
conjugated anti-FLAG antibody (Sigma-Aldrich #A8592, 1:2500) for 1 h,
bound DARPins were detected through the addition of 20 µl of an Amplex
UltraRed mixture (Thermo Fisher Scientific; prepared according the
manufacturer’s instructions). Turnover of the substrate was monitored at
27°C on a Synergy™HTMicroplate Reader. All values were determined in
triplicates.
For the competition ELISA, mTFP1 was immobilized on plates through its
SBP-tag as described above and incubated for 1 h with 20 µl of 100 nM
FLAG-tagged anti-mTFP1 DARPins alone or in combination with 500 nM
HA-tagged competitor DARPins (non-binding DARPin E3_5 as well as
either of the two anti-mTFP1 DARPins). For detection of the bound FLAG-
tagged DARPins, wells were incubated for 1 h each with a primary mouse
anti-FLAG antibody (Sigma-Aldrich #F3165, 1:5000) and secondary goat
anti-mouse-AP antibody (Sigma-Aldrich #A3562, 1:10,000), followed by the
addition of 20 µl per well of a 3 mM p-nitrophenyl phosphate solution
(Sigma-Aldrich, #71768). Absorption was measured 30 min after incubation
at 37°C at 405 nm. All measurements represent technical triplicates.
The FA assay was performed as described previously (Brauchle et al.,
2014) using black non-binding 96-well plates (Greiner). Constant amounts
of mTFP1 (15 nM) were titrated with a dilution series of DARPins (four
replicates) and the fluorescence anisotropy was measured on a TecanM1000
equipped with a suitable anisotropy module. The KD was determined by
fitting the data with a non-linear fit using GraphPad Prism.
Crystallization, data collection and structure determination
All crystallization experiments were carried out with 15 mg/ml protein in
sitting-drop vapour diffusion experiments. mTFP1/DARPin 1238_E11
crystals in space group C2 grew after 2 days at 4°C in 10% PEG4000, 20%
glycerol and 0.02 M of L-glutamate, glycine, DL-alanine, L-lysine, DL-
serine. mTFP1/DARPin 1238_E11 crystals in space group P6522 grew
within 1 week in 0.1 M imidazole pH 7.0 and 30% 2-methyl-2,4-
pentanediol at 20°C. Plate-like crystals of DARPin 1238_G01 in space
group I4 appeared after 1 week in 2 M NaCl, 10% PEG10,000 at 20°C and
grew to their final size within 2 weeks. Crystals of isolated DARPin
1238_E11 in space group P21 grew after 2 months in 0.2 M (NH4)2SO4,
0.1 MMES pH 6.5, 20% PEG8000 at room temperature. Rod-like DARPin
1238_G01 crystals in space group P212121 grew within 2 days in 0.2 M
NaF, 20% PEG3350 at 20°C. mTFP1/DARPin 1238_E11 crystals were
directly frozen in liquid nitrogen. DARPin 1238_E11 and DARPin
1238_G01 crystals were cryo-preserved by addition of ethylene glycol to
a final concentration of 20% (v/v) and flash-cooled in liquid nitrogen. All
measurements were done at the SLS beamlines X06DA and X06SA (Swiss
Light Source, Paul Scherrer Institute, Switzerland) at 100K. All data were
integrated, indexed and scaled using the XDS software package (Kabsch,
2010a,b). Data collection statistics are summarized in Table S1. The
structures were solved by molecular replacement using the crystal structure of
anti-IL4 DARPin (PDB ID: 4YDY) and mTFP1 (PDB ID: 2HQK) (Ai et al.,
2006) as search models with the program Phaser (McCoy et al., 2007). Model
building, structure refinement and model validation were performed with
Coot (Emsley and Cowtan, 2004), PHENIX (Adams et al., 2002), Refmac5
(Murshudov et al., 2011) and Molprobity (Chen et al., 2010), respectively.
Refinement statistics are summarized in Table S1. The atomic coordinates
have been deposited in the RCSB Protein Data Bank and are available under
the accession code 6FP7, 6FP8, 6FP9, 6FPA and 6FPB, respectively.
Plasmid construction
All the eukaryotic expression plasmids were generated by specific PCR
amplification and standard restriction cloning. Briefly, anti-mTFP1
DARPins, including the N-terminal His-tag and the C-terminal Flag-tag,
were PCR amplified from the bacterial expression constructs and inserted
into pmCherry (Hybrigenics, France). For the DARPins-YPet fusions, the
mCherry coding sequence was replaced by the YPet coding sequence by
standard PCR and restriction cloning. The additional polyisoprenylation
CAAX peptide (GGGRSKLNPPDESGPGCMSCKCVLS) of the humanK-
Ras oncogene protein, or the whole human HISTH2BJ (histone H2B)
coding sequence were inserted at the C-terminus of the DARPins-YPet
fusion constructs for generating the membrane- (DARPins-YPet-CAAX) or
nuclear (DARPins-YPet-H2B) tethering DARPins. The mitochondrial bait
mito-mTFP1, containing an N-terminal anchor sequence from the human
CISD1 protein (the first 59 amino acids) fused to the N-terminus of mTFP1,
was generated from pcDNA4TO-mito-mCherry-10xGCN4_v4 [Addgene
plasmid 60914 (Tanenbaum et al., 2014)] by substituting the mCherry
coding sequencewith that of mTFP1 and substituting the 10xGCN4_v4 tags
with 1xGCN4_v4 tag. mTFP1-CAAX and HIST2BJ-mTFP1 were cloned
into CMV expression vectors (pmKate2-N, Evrogen) replacing mKate2
with mTFP1 coding sequences. For the mTFP1-Rab5c fusion construct,
both coding sequences of mTFP1 and zebrafish (Danio rerio) Rab5c were
cloned in this order into pcDNA3 (Invitrogen) by standard PCR and
restriction cloning. All constructs were verified by sequencing. Plasmid
maps and oligonucleotide sequences for PCR and cloning are available
upon request. A schematic representation of the fusion constructs is
provided in Fig. S4 and their resulting fusion protein amino acid sequences
are given in Table S2.
Cell cultures, transfections and imaging
HeLa S3α cells (routinely checked for mycoplasm contamination) were
maintained in Dulbecco’s modified Eagle’s medium supplemented with
10% foetal calf serum, 100 IU penicillin and 100 µg streptomycin per ml.
One day before transfection, cells were seeded on glass cover slip placed
into a 24-well plate at a density of 50,000-100,000 cells/well.
Transfections were carried out with 1 µg of total DNA (500 ng for each
construct or with empty expression plasmid) and 3 µl of FuGENE® HD
Transfection Reagent (Promega), according to themanufacturer’s instructions.
24 h post transfection, cells were fixed in 4% paraformaldehyde, stained with
Hoechst 33342 (Invitrogen) and mounted on standard microscope slides with
VECTASHIELD® (Vector Laboratories Inc., Burlingame, USA).
Confocal images were acquired with a Leica point scanning confocal
‘SP5-II-MATRIX’ microscope (Imaging Core Facility, Biozentrum,
University of Basel) with a 63× HCX PLAN APO lambda blue objective
and 1-2×zoom.
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